Patients with ZSD have increased risk of low bone mineral density.
Low bone mineral density does not exist primarily due to disuse or low vitamin D.
Treatment with bisphosphonates may improve low bone mineral density.
A mechanism for low bone mineral density involving PPAR-gamma is hypothesized.